Diovan

Forget The Apology: Japan To Raid Novartis Offices Over Diovan Scandal
Pharmalot
Fri, 09/27/13 - 11:47 am
Japan
Novartis
Diovan
New Ranbaxy import ban provides Novartis with unexpected benefit
Fierce Pharma
Mon, 09/16/13 - 11:06 am
Ranbaxy
Novartis
Diovan
generics
Why Is Novartis in Trouble in Japan?
Wall St. Cheat Sheet
Tue, 08/13/13 - 10:47 am
Japan
Novartis
Diovan
More Bad News For Novartis Blood Pressure Drug
Forbes
Tue, 07/30/13 - 01:12 pm
Novartis
Diovan
antihypertensives
Diovan Data Was Fabricated, Say Japanese Health Minister And University Officials
Forbes
Sat, 07/13/13 - 12:10 pm
Diovan
Novartis
Novartis Acknowledges Employees Participated In 'Independent' Trials
Forbes
Thu, 05/23/13 - 11:29 am
Novartis
clinical trials
Diovan
Mylan Suit Against FDA Over Generic Heart Drug Dismissed
Bloomberg
Thu, 12/27/12 - 10:35 pm
generics
Mylan
FDA
Diovan
Novartis Drug Diovan Retains 69% of Prescriptions in U.S.
Bloomberg
Tue, 10/16/12 - 10:51 am
Novarits
Diovan
generics
Sandoz
Mylan Sues FDA for Approval of Generic Version of Diovan
Bloomberg
Wed, 10/3/12 - 10:48 am
FDA
Mylan
Diovan
generics
Ranbaxy
Novartis
Where is Ranbaxy's copycat version of Diovan?
Fierce Pharma
Wed, 09/26/12 - 12:13 pm
generics
Diovan
Novartis
Ranbaxy
antihypertensives
Diovan Generic Launched by Mylan
Yahoo/Zacks
Mon, 09/24/12 - 05:57 pm
Mylan
Diovan
generics
Novartis
antihypertensives
Mylan and Novartis start selling generic Diovan
Yahoo/AP
Sat, 09/22/12 - 03:34 pm
Mylan
Novartis
Diovan
generics
Co-pay coupons lifted Lipitor. Can they defend Diovan?
Fierce Pharma
Tue, 08/21/12 - 05:10 pm
co-pay coupons
Lipitor
Pfizer
Diovan
Novartis
Plavix
Bristol-Myers Squibb
Nexium, Actos, or Diovan? Analysts try to ID Ranbaxy's 3 sacrifices
Fierce Pharma
Fri, 01/27/12 - 12:17 pm
Nexium
Actos
Diovan
Ranbaxy
10 largest upcoming pharma patent losses in the US
Fierce Pharma
Tue, 10/25/11 - 11:54 am
Takeda
Actos
Forest Labs
Lexapro
Bristol-Myers Squibb
Plavix
AstraZeneca
Seroquel
Eli Lilly
Zyprexa
Pfizer
Lipitor
Merck
Singulair
Novartis
Diovan
Provigil
Teva Pharmaceuticals
Abbott Laboratories
TriCor
Novartis’s Jimenez Has Blockbuster Plans for Diovan After Patent Expires
Bloomberg
Fri, 08/5/11 - 11:46 am
Diovan
Novartis
Joe Jimenez
Analysts Positive on Novartis Despite Hypertension Drug Patent Expiration
Seeking Alpha
Thu, 11/18/10 - 06:37 pm
Novartis
hypertension
Diovan
patents
FDA takes a closer look at possible cancer risks of widely used blood pressure medicines
Star Ledger, NJ
Fri, 07/16/10 - 09:26 am
FDA
cancer
ARBs
Merck
Cozaar
Bristol-Myers Squibb
Avapro
Atacand
Benicar
Diovan
Micardis
Teveten
Common Blood Pressure Pills Linked To Cancer
Forbes
Mon, 06/14/10 - 12:15 pm
cancer
ARBs
Benicar
Daiichi Sankyo
Micardis
Boehringer Ingelheim
Merck
Cozaar
Novartis
Diovan
Takeda blood pressure drug tops rivals in studies
Reuters
Mon, 05/3/10 - 01:19 pm
antihypertensives
Takeda
azilsartan
Diovan
Benicar

Pages